FR3101774B1 - Composition cicatrisante et conductrice comprenant au moins deux collagenes - Google Patents

Composition cicatrisante et conductrice comprenant au moins deux collagenes Download PDF

Info

Publication number
FR3101774B1
FR3101774B1 FR1911192A FR1911192A FR3101774B1 FR 3101774 B1 FR3101774 B1 FR 3101774B1 FR 1911192 A FR1911192 A FR 1911192A FR 1911192 A FR1911192 A FR 1911192A FR 3101774 B1 FR3101774 B1 FR 3101774B1
Authority
FR
France
Prior art keywords
collagens
healing
collagen
conductive composition
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1911192A
Other languages
English (en)
Other versions
FR3101774A1 (fr
Inventor
Emanuele Monderna
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Monderna Health and Wellness SAS
Original Assignee
Monderna Health and Wellness SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Monderna Health and Wellness SAS filed Critical Monderna Health and Wellness SAS
Priority to FR1911192A priority Critical patent/FR3101774B1/fr
Priority to PCT/EP2020/078473 priority patent/WO2021069698A1/fr
Publication of FR3101774A1 publication Critical patent/FR3101774A1/fr
Application granted granted Critical
Publication of FR3101774B1 publication Critical patent/FR3101774B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/805—Corresponding aspects not provided for by any of codes A61K2800/81 - A61K2800/95
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/06—Electrodes for high-frequency therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/40—Applying electric fields by inductive or capacitive coupling ; Applying radio-frequency signals
    • A61N1/403—Applying electric fields by inductive or capacitive coupling ; Applying radio-frequency signals for thermotherapy, e.g. hyperthermia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)

Abstract

L’invention concerne une composition adaptée à une application topique sur la peau ou les muqueuses, caractérisée en ce qu’elle comprend au moins de l’eau et au moins un mélange de collagènes, ledit mélange de collagène comprenant au moins :- du collagène natif, les molécules de collagène natif présentant des poids moléculaires compris entre 150 et 300 000 Daltons, et - du collagène en gel, les molécules de collagène en gel présentant des poids moléculaires compris entre 100 et 150 000 Daltons. L’invention a également pour objet une telle composition pour son utilisation dans le traitement de la peau et/ou des muqueuses et un procédé de fabrication d’une telle composition.
FR1911192A 2019-10-09 2019-10-09 Composition cicatrisante et conductrice comprenant au moins deux collagenes Active FR3101774B1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR1911192A FR3101774B1 (fr) 2019-10-09 2019-10-09 Composition cicatrisante et conductrice comprenant au moins deux collagenes
PCT/EP2020/078473 WO2021069698A1 (fr) 2019-10-09 2020-10-09 Composition cicatrisante et conductrice comprenant du collagene

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1911192 2019-10-09
FR1911192A FR3101774B1 (fr) 2019-10-09 2019-10-09 Composition cicatrisante et conductrice comprenant au moins deux collagenes

Publications (2)

Publication Number Publication Date
FR3101774A1 FR3101774A1 (fr) 2021-04-16
FR3101774B1 true FR3101774B1 (fr) 2023-12-29

Family

ID=69375490

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1911192A Active FR3101774B1 (fr) 2019-10-09 2019-10-09 Composition cicatrisante et conductrice comprenant au moins deux collagenes

Country Status (1)

Country Link
FR (1) FR3101774B1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118948706B (zh) * 2024-09-20 2025-07-11 浙江章光101有限公司 一种中药组合物及其制备方法及应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2657352B1 (fr) * 1990-01-25 1993-08-13 France Etat Armement Nouveau produit biologique de remplacement du tissu conjonctif, a structure composite a base de collagene, et procede pour sa preparation.
FR2732972B1 (fr) * 1995-04-14 1997-07-11 Mathe Lab Procede pour la preparation d'une composition de collagene et composition ainsi obtenue
US8748499B2 (en) * 2009-04-10 2014-06-10 Interhealth Nutraceuticals, Inc. Collagen dispersion and method of producing same
CN113318058A (zh) * 2018-08-27 2021-08-31 白晋 胶原蛋白补充剂、射频美容用自体胶原蛋白液及其使用方法和应用

Also Published As

Publication number Publication date
FR3101774A1 (fr) 2021-04-16

Similar Documents

Publication Publication Date Title
DE602004028455D1 (de) Vernetzte polysaccharidzusammensetzung
BRPI0408317A (pt) anticorpos do receptor de igf-i para o tratamento de cáncer
BR112014026088A2 (pt) produto de tratamento de tecidos, estojo, método de fabricação de um produto de tratamento de tecidos, método de tratamento, e uso do produto de tratamento de tecidos
BR0315688A (pt) Compostos, composições farmacêuticas e seus usos no tratamento ou prevenção de doenças ou condições de proliferação celular metabólicas
MX2022009390A (es) Compuestos de unión a il-7r¿¿c.
EP2497478A3 (fr) Composition d'oligosaccarides et leur utilisation dans le traitement d'infection
EP1401421A4 (fr) Methodes et compositions pour le traitement de l'onychomycose et autres pathologies microbiennes et mycosiques
EP1688106A3 (fr) Dispositif orthopédique pour corriger des malpositions des orteils
MA28935B1 (fr) Preparation et utilisation de derives de biphenyl-4-yl-carbonylamino-acide dans le traitement de l'obesite
CL2009001001A1 (es) Anticuerpo anti-factor d del complemento; polinucleotido codificante; vector que comprende dicho polinucleotido; celula huesped que comprende dicho vector; metodo de fabricacion del anticuerpo; composicion farmaceutica que lo comprende; uso del anticuerpo para tratar trastornos inflamatorios o trastornos oculares.
BR0312818A (pt) uso de um composto capaz de ligar ao receptor flt- 1 solúvel (sflt-1), kit para doagnosticar pré-eclámpsia ou eclámpsia , método para identificar esse composto e respectiva composição farmacêutica
WO2007126439A3 (fr) Compositions et méthodes de traitement de maladies et troubles associés é la signalisation de la cytokine
BR9908182A (pt) Composições de proteìna de matriz para cura deferidas
EA202190310A1 (ru) Белок для лечения воспалительных заболеваний
FR3101774B1 (fr) Composition cicatrisante et conductrice comprenant au moins deux collagenes
MA52961A (fr) Compositions et procédés pour la réduction ou le traitement d'une inflammation
CA2446549A1 (fr) Composition cosmetique a base de sucralfate et de sulfates de cuivre et de zinc
EP0734725A3 (fr) Adjuvants contenant des composés de fer colloidaux
BR0207528A (pt) Anticorpo, composição farmacêutica, e, usos de uma quantidade efetiva de um agente, de uma quantidade terapeuticamente efetiva de um anticorpo para il-22, de uma quantidade imunogênica do antìgeno e uma quantidade aumentadora de imunogenicidade de il-22 em combinação, de uma quantidade efetiva do anticorpo ou fragmento do mesmo e de uma quantidade suficiente de anticorpo ou fragmento ligado a antìgeno do mesmo
DE60115349D1 (de) Polymorphismen im Gen für den humanen organischen Anionentransporter C (OATP-C)
FR3091650B1 (fr) Produit pour le traitement de dysbioses
AR004360A1 (es) Composiciones farmaceuticas para la terapia de carcinomas del epitelio plano y un agente para ser empleado en estas composicines farmaceuticas.
ATE393573T1 (de) Zusammensetzungen für die systemische verabreichung von sequenzen, die für knochenmorphogenese-proteinen kodieren
FR3077204B1 (fr) Extraits de fruit de myrciaria dubia riche en acides organiques, compositions cosmetiques le comprenant et leurs utilisations cosmetiques
DE60312684D1 (de) Plazenta-wachstumsfaktor als target für die behandlung von osteoporose

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20210416

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7